Literature DB >> 20061116

Metabonomics study of urine from Sprague-Dawley rats exposed to Huang-yao-zi using (1)H NMR spectroscopy.

Yanru Liu1, Rongqing Huang, Lijun Liu, Jiangnan Peng, Bingkun Xiao, Jianyun Yang, Zhenchun Miao, Honglin Huang.   

Abstract

Urinary metabolic perturbations associated with liver toxicity induced by Huang-yao-zi (root of Dioscorea bulifera L.) were studied using nuclear magnetic resonance spectroscopy ((1)H NMR) to determine the correlations between metabonomic profiling and histopathologic/biochemical observations and to discover biomarkers for liver toxicity. Huang-yao-zi with a maximal tolerance dose (MTD) was given to male Sprague-Dawley rats for 72h followed by metabonomic analysis of urine samples collected at 24 and 72h. The results revealed that the levels of taurine, creatine, betaine, dimethylglycine (DMG), acetate, glycine were elevated, whereas, the levels of succinate, 2-oxoglutarate, citrate, hippurate and urea were reduced. Partial least square (PLS)-discrimination analysis (DA) of NMR spectra revealed two apparent clusters between control groups and treatment groups, indicating metabolic changes observed in urine samples in response to Huang-yao-zi treatment. In addition, mechanism associated with oxidative injury of hepatic mitochondria was investigated. These results indicated that (1)H NMR-based metabonomics analysis in urine samples may be useful for predicting hepatotoxicity induced by Huang-yao-zi. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20061116     DOI: 10.1016/j.jpba.2009.12.026

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  11 in total

1.  A critical assessment of feature selection methods for biomarker discovery in clinical proteomics.

Authors:  Christin Christin; Huub C J Hoefsloot; Age K Smilde; B Hoekman; Frank Suits; Rainer Bischoff; Peter Horvatovich
Journal:  Mol Cell Proteomics       Date:  2012-10-31       Impact factor: 5.911

Review 2.  The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment.

Authors:  Marta Moreno-Torres; Guillermo Quintás; José V Castell
Journal:  Metabolites       Date:  2022-06-19

Review 3.  The metabolomic window into hepatobiliary disease.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  J Hepatol       Date:  2013-05-25       Impact factor: 25.083

4.  Detailed mitochondrial phenotyping by high resolution metabolomics.

Authors:  James R Roede; Youngja Park; Shuzhao Li; Frederick H Strobel; Dean P Jones
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

Review 5.  Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review.

Authors:  Abdul-Hamid Emwas; Claudio Luchinat; Paola Turano; Leonardo Tenori; Raja Roy; Reza M Salek; Danielle Ryan; Jasmeen S Merzaban; Rima Kaddurah-Daouk; Ana Carolina Zeri; G A Nagana Gowda; Daniel Raftery; Yulan Wang; Lorraine Brennan; David S Wishart
Journal:  Metabolomics       Date:  2014-11-21       Impact factor: 4.290

6.  Metabolic Profiling Analysis of the Alleviation Effect of the Fractions of Niuhuang Jiedu Tablet on Realgar Induced Toxicity in Rats.

Authors:  Wenfeng Xu; Yuehu Pei; Shuo Xu; Haifeng Wang; Pengfei Jin
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-23       Impact factor: 2.629

Review 7.  Application of metabolomics in toxicity evaluation of traditional Chinese medicines.

Authors:  Li Duan; Long Guo; Lei Wang; Qiang Yin; Chen-Meng Zhang; Yu-Guang Zheng; E-Hu Liu
Journal:  Chin Med       Date:  2018-12-04       Impact factor: 5.455

Review 8.  Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary Analysis.

Authors:  Abdul-Hamid Emwas; Raja Roy; Ryan T McKay; Danielle Ryan; Lorraine Brennan; Leonardo Tenori; Claudio Luchinat; Xin Gao; Ana Carolina Zeri; G A Nagana Gowda; Daniel Raftery; Christoph Steinbeck; Reza M Salek; David S Wishart
Journal:  J Proteome Res       Date:  2016-01-20       Impact factor: 4.466

Review 9.  The Need for Biomarkers in Diagnosis and Prognosis of Drug-Induced Liver Disease: Does Metabolomics Have Any Role?

Authors:  Paula Iruzubieta; Maria Teresa Arias-Loste; Lucía Barbier-Torres; Maria Luz Martinez-Chantar; Javier Crespo
Journal:  Biomed Res Int       Date:  2015-12-28       Impact factor: 3.411

10.  Psychopharmacological effects of riparin III from Aniba riparia (Nees) Mez. (Lauraceae) supported by metabolic approach and multivariate data analysis.

Authors:  Sócrates Golzio Dos Santos; Isis Fernandes Gomes; Adriana Maria Fernandes de Oliveira Golzio; Augusto Lopes Souto; Marcus Tullius Scotti; Josean Fechine Tavares; Stanley Juan Chavez Gutierrez; Reinaldo Nóbrega de Almeida; José Maria Barbosa-Filho; Marcelo Sobral da Silva
Journal:  BMC Complement Med Ther       Date:  2020-05-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.